Concepedia

Ling Jin

LJ

56

Publications

2.3K

Citations

26

H-Index

2006

Active since

Affiliations

Eli Lilly (United States)(Current)

Peking University

Chinese Academy of Medical Sciences & Peking Union Medical College

University of Toronto

Université Libre de Bruxelles

Ling Jin is an author at Eli Lilly (United States) specializing in medicine, signal transduction, and cell biology.

ORCID

Top concepts

Publications per year

2006–2023

56

Publications

56

Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients

Lei Ye, Jing Li, Ling Jin et al. · Scientific Reports · 2018 · 357 citations · Full text

A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti–Interleukin‐17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors

Mark C. Genovese, Maria Greenwald, Chul‐Soo Cho et al. · Arthritis & Rheumatology · 2014 · 202 citations · Full text

AK098656, a Novel Vascular Smooth Muscle Cell–Dominant Long Noncoding RNA, Promotes Hypertension

Ling Jin, Xianjuan Lin, Lei Yang et al. · Hypertension · 2017 · 96 citations · Full text

Seizure risk in patients with attention‐deficit‐hyperactivity disorder treated with atomoxetine

Joachim Wernicke, Karen C. Holdridge, Ling Jin et al. · Developmental Medicine & Child Neurology · 2007 · 89 citations · Full text

Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial

Mohit Bhandari, Ling Jin, Kyoungah See et al. · Clinical Orthopaedics and Related Research · 2016 · 86 citations · Full text

Rows per page

1–5 of 56